Call for papers - Overcoming therapy resistance in prostate cancer
December 27, 2023
ESJ seeks submissions to a new Collection, focused on understanding and combating resistance mechanisms in advanced prostate cancer.
Read more about Call for papers - Overcoming therapy resistance in prostate cancer
Mandatory Metadata
December 27, 2023
Since June 2021, ORCID* is mandatory for all authors when submitting to ESJ Journal.
Impact Factor 2022 increased to. 4.6
December 27, 2023
New Impact factor 2022 increased to 4.6.
ESJ Journal reaches the first JIF quartile of category Biology.